Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.39 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.32 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4845406 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9098929 | 0.96 | — | — | |
| SCHEMBL575245 | 0.86 | CHRNA7 (0.33) | CHRNA7 | |
| SCHEMBL575435 | 0.84 | — | — | |
| SCHEMBL9864651 | 0.84 | — | — | |
| SCHEMBL17550748 | 0.84 | CHRNA7 (0.36) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL575736 | 0.83 | CHRNA7 (0.37) | CHRNA7 | |
| Hydrochloric Acid SCHEMBL15366520 | 0.81 | CHRNA7 (0.34) | CHRNA7 | |
| Water SCHEMBL16297127 | 0.81 | CHRNA7 (0.34) | CHRNA7 | |
| SCHEMBL2865219 | 0.81 | CHRNA7 (0.34) | CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240117081-A1 | POLYMERIZABLE COMPOSITION, VEHICLE, CURED MATERIAL, AND METHOD OF MANUFACTURING CURED MATERIAL | ADEKA CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| EP-3232455-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR ELECTRIC DOUBLE LAYER CAPACITORS | OTSUKA CHEMICAL CO LTD (JP) | 2023-10-25 | — | — | EP | disclosed |
| US-11618742-B2 | Radical polymerization initiator, composition containing same, cured product of composition, production method for cured product, and compound | ADEKA CORPORATION (JP) | 2023-04-04 | — | — | US | disclosed |
| US-11616253-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-03-28 | — | — | US | disclosed |
| US-11591308-B2 | — | — | 2023-02-28 | — | — | US | disclosed |
| US-11367899-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-06-21 | — | — | US | disclosed |
| US-20210107887-A1 | RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND | ADEKA CORPORATION (JP) | 2021-04-15 | — | — | US | disclosed |
| EP-3753958-A1 | RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND | ADEKA CORPORATION (JP) | 2020-12-23 | — | — | EP | disclosed |
| US-10593488-B2 | Nonaqueous electrolytic solution for electric double layer capacitors | OTSUKA CHEMICAL CO., LTD. (JP) | 2020-03-17 | — | — | US | disclosed |
| US-10468720-B2 | Nonaqueous electrolyte for secondary battery and nonaqueous-electrolyte secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2019-11-05 | — | — | US | disclosed |
| US-20100035146-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2144321-A1 | NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-01-13 | — | — | EP | disclosed |
| EP-2120279-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-11-18 | — | — | EP | disclosed |
| EP-2093191-A1 | ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2009-08-26 | — | — | EP | disclosed |
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20080271381-A1 | Method for manufacturing stabilized polyacetal resin, stabilized polyacetal resin, stabilized polyacetal resin composition, and molded article of stabilized polyacetal resin | POLYPLASTICS CO., LTD (JP) | 2008-11-06 | — | — | US | disclosed |
| US-20080094777-A1 | Electric double layer capacitor | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-04-24 | — | — | US | disclosed |
| EP-1905740-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-04-02 | — | — | EP | disclosed |
| EP-1876611-A1 | ELECTRIC DOUBLE LAYER CAPACITOR | Sumitomo Chemical Company, Limited (JP) | 2008-01-09 | — | — | EP | disclosed |
| EP-1867667-A1 | Method for manufacturing stabilized polyacetal resin, stabilized polyacetal resin, stabilized polyacetal resin composition, and molded article of stabilized polyacetal resin | Polyplastics Co., Ltd. (JP) | 2007-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11591308-B2 | — | RER1, CBR1, H1-10 | CHRNA7 3988/4885CHRNA10 2495/4885CHRNA9 4123/4885 |
| US-20090103241-A1 | Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 | CBR1, CYP24A1, CALU | CHRNA7 1263/4885CHRNA10 1181/4885CHRNA9 1158/4885 |
| US-11618742-B2 | Radical polymerization initiator, composition containing same, cured product of composition, production method for cured product, and compound | ASH2L, RER1, BOLA2; BOLA2B | CHRNA7 4060/4885CHRNA10 2752/4885CHRNA9 3945/4885 |
| US-20210107887-A1 | RADICAL POLYMERIZATION INITIATOR, COMPOSITION CONTAINING SAME, CURED PRODUCT OF COMPOSITION, PRODUCTION METHOD FOR CURED PRODUCT, AND COMPOUND | RRP12, ASH2L, RER1 | CHRNA7 3758/4885CHRNA10 2895/4885CHRNA9 3255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.